Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 20

Sort by

Sort Order Select

Journal Articles

The Differential Impact of Secondary-Type Mutations in a Multinational Cohort of 5311 Intensively Treated Acute Myeloid Leukemia Patients

Jan-Niklas Eckardt, Marius Bill, Konstanze Döhner, Christian Rausch, Klaus H Metzeler, Karsten Spiekermann, Sebastian Stasik, Tim Sauer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. H. Brummendorf, Utz Krug, Bernhard Wörmann, Hermann Einsele, Wolfgang Hiddemann, Dennis Görlich, Maria Cristina Sauerland, Björn Steffen, Andreas Neubauer, Andreas Burchert, Kerstin Schaefer-Eckart, Wolfgang E. Berdel, Christoph Schliemann, Stefan W. Krause, Mathias Hänel, Maher Hanoun, Martin Kaufmann, Lars Fransecky, Jan Braess, Johannes Schetelig, Jan Moritz Middeke, Lars Bullinger, Michael Heuser, Felicitas R Thol, Hubert Serve, Claudia D Baldus, Uwe Platzbecker, Carsten Mueller-Tidow, Barbora Weinbergerova, Jiri Mayer, Pierre-Yves Dumas, Sarah Bertoli, Eric Delabesse, Christian Récher, Arnaud Pigneux, Tobias Herold, Arnold Ganser, Hartmut Döhner, Martin Bornhäuser, Christian Thiede, Christoph Röllig

Blood (2024) 144 (Supplement 1): 2934.

https://doi.org/10.1182/blood-2024-201945

Published: 2024

Journal Articles

Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1 -Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

Blood (2023) 142 (Supplement 1): 721.

https://doi.org/10.1182/blood-2023-186160

Published: 2023

Journal Articles

D DX41 -Low Expression Mimics Germline DDX41 -Phenotype in Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 820.

https://doi.org/10.1182/blood-2023-187419

Published: 2023

Journal Articles

Risk Stratification of Patients with RUNX1- mutated Acute Myeloid Leukemia

Blood (2023) 142 (Supplement 1): 2934.

https://doi.org/10.1182/blood-2023-174059

Published: 2023

Journal Articles

Secondary Neoplasms in AML Long-Term Survivors: Even More Cancer to Come?

Anna Sophia Moret, Eva Telzerow, Maria Cristina Sauerland, Simon M. Krauss, Maja Rothenberg-Thurley, Friederike H.A. Mumm, Jan Braess, Bernhard J. Wörmann, Utz Krug, Wolfgang E. Berdel, Wolfgang Hiddemann, Karsten Spiekermann, Pia Heußner, Dennis Görlich, Klaus H. Metzeler

Blood (2022) 140 (Supplement 1): 690–691.

https://doi.org/10.1182/blood-2022-163530

Published: 2022

Journal Articles

Life Satisfaction and Quality of Life in AML Long-Term Survivors: Primary Results of the AMLCG-Survivorship Study

Eva Telzerow, Dennis Görlich, Maria Cristina Sauerland, Anna Sophia Moret, Maja Rothenberg-Thurley, Simon M. Krauss, Friederike H.A. Mumm, Susanne Amler, Wolfgang E. Berdel, Bernhard J. Wörmann, Utz Krug, Jan Braess, Pia Heußner, Wolfgang Hiddemann, Karsten Spiekermann, Klaus H. Metzeler

Blood (2022) 140 (Supplement 1): 5293–5295.

https://doi.org/10.1182/blood-2022-165429

Published: 2022

Journal Articles

German AMLCG-Survivorship Study: Anxiety and Depression Symptoms in AML Long-Term Survivors

Dennis Görlich, Eva Telzerow, Maria Cristina Sauerland, Anna Sophia Moret, Maja Rothenberg-Thurley, Friederike H.A. Mumm, Susanne Amler, Wolfgang E. Berdel, Bernhard J. Wörmann, Utz Krug, Jan Braess, Pia Heußner, Wolfgang Hiddemann, Karsten Spiekermann, Klaus H. Metzeler

Blood (2022) 140 (Supplement 1): 942–943.

https://doi.org/10.1182/blood-2022-156647

Published: 2022

Journal Articles

Sex-Associated Differences in Frequencies and Outcome Prognostication of Recurrent Molecular Features in Adults with Acute Myeloid Leukemia (AML) (AMLCG, CALGB [Alliance])

Blood (2022) 140 (Supplement 1): 936–939.

https://doi.org/10.1182/blood-2022-165395

Published: 2022

Journal Articles

Validation of the 2022 European Leukemianet Genetic Risk Stratification of Acute Myeloid Leukemia

Christian Rausch, Maja Rothenberg-Thurley, Annika Maria Dufour, Stephanie Schneider, Hanna Gittinger, Maria Cristina Sauerland, Dennis Görlich, Utz Krug, Wolfgang E. Berdel, Bernhard Josef Woermann, Wolfgang Hiddemann, Jan Braess, Karsten Spiekermann, Tobias Herold, Klaus H. Metzeler

Blood (2022) 140 (Supplement 1): 3408–3409.

https://doi.org/10.1182/blood-2022-167022

Published: 2022

Journal Articles

Quality of Life and Life Satisfaction in AML Long-Term Survivors: Primary Results of the AMLCG-Survivorship Study

Eva Telzerow, Dennis Görlich, Maja Rothenberg-Thurley, Maria Cristina Sauerland, Anna Sophia Moret, Friederike H. A. Mumm, Susanne Amler, Wolfgang E. Berdel, Bernhard J. Wörmann, Utz Krug, Jan Braess, Pia Heußner, Wolfgang Hiddemann, Karsten Spiekermann, Klaus H. Metzeler

Blood (2021) 138 (Supplement 1): 2289.

https://doi.org/10.1182/blood-2021-147027

Published: 2021

Journal Articles

Multi-Dimensional Analysis of Adult Acute Myeloid Leukemia (AML) Landscape Cross-Continents Reveals Age Associated Trends in Mutations and Outcomes

Blood (2021) 138 (Supplement 1): 685.

https://doi.org/10.1182/blood-2021-153015

Published: 2021

Journal Articles

High Prevalence of CHF and Diabetes in AML Long-Term Survivors - a Patient Forever?

Anna Sophia Moret, Eva Telzerow, Maja Rothenberg-Thurley, Maria Cristina Sauerland, Elke Burgard, Friederike H. A. Mumm, Jan Braess, Bernhard J. Wörmann, Utz Krug, Wolfgang E. Berdel, Wolfgang Hiddemann, Karsten Spiekermann, Pia Heußner, Klaus Kraywinkel, Dennis Görlich, Klaus H. Metzeler

Blood (2021) 138 (Supplement 1): 4127.

https://doi.org/10.1182/blood-2021-149149

Published: 2021

Journal Articles

PTPN11 mutations and Outcomes in Adult Patients with Acute Myeloid Leukemia

Klaus H. Metzeler, MD, Maja Rothenberg-Thurley, PhD, Dennis Görlich, PhD, Maria Cristina Sauerland, Annika Maria Dufour, PhD, Stephanie Schneider, PhD, Marion Subklewe, MD, Jan Braess, MD, Bernhard J. Wörmann, MD, Wolfgang E. Berdel, Prof., MD, Utz Krug, MD, Wolfgang Hiddemann, MD PhD, Karsten Spiekermann, MD, Tobias Herold, MD

Blood (2020) 136 (Supplement 1): 4–5.

https://doi.org/10.1182/blood-2020-137487

Published: 2020

Journal Articles

DNA Methylation Profiling of AML Reveals Epigenetic Subgroups with Distinct Clinical Outcome

Sebastian Vosberg, Paul Kerbs, MSc, Vindi Jurinovic, MSc, Klaus H. Metzeler, MD, Susanne Amler, PhD, Cristina Sauerland, Dennis Görlich, PhD, Wolfgang E. Berdel, MD, Jan Braess, MD, Wolfgang Hiddemann, MD PhD, Karsten Spiekermann, MD, Tobias Herold, MD, Philipp A. Greif, MD PD

Blood (2019) 134 (Supplement_1): 2715.

https://doi.org/10.1182/blood-2019-130047

Published: 2019

Journal Articles

NPM1 Variant Allele Frequency and Outcomes in AML

Blood (2018) 132 (Supplement 1): 1486.

https://doi.org/10.1182/blood-2018-99-112549

Published: 2018

Journal Articles

Aldehyde Dehydrogenase 2 ( ALDH2 ) Expression Predicts a Poor Prognosis in Acute Myeloid Leukemia

Linus Angenendt, Eike Bormann, Jan-Henrik Mikesch, Tobias Herold, Klaus H. Metzeler, MD, Stefan K. Bohlander, MD, Dennis Görlich, Maria Francisca Arteaga, Bernhard J. Wörmann, Georg Lenz, Wolfgang Hiddemann, Karsten Spiekermann, Utz Krug, Christina Sauerland, Wolfgang E. Berdel, Christoph Schliemann

Blood (2017) 130 (Supplement 1): 1386.

https://doi.org/10.1182/blood.V130.Suppl_1.1386.1386

Published: 2017

Journal Articles

PS29MRC - a Novel Predictive Score for Response to Therapy in Acute Myeloid Leukemia

Blood (2016) 128 (22): 1209.

https://doi.org/10.1182/blood.V128.22.1209.1209

Published: 2016

Journal Articles

High Expression of ARMCX1 Predicts Poor Survival in Intensively Treated Older Acute Myeloid Leukemia Patients (≥ 60 years)

Jan-Henrik Mikesch, MD, Christina Sauerland, Dipl.-Math, Tobias Herold, MD, Dennis Görlich, Eike Bormann, Wolfgang Hartmann, MD, Christoph Schliemann, MD, Bernhard J Wörmann, MD, Wolfgang Hiddemann, Karsten Spiekermann, MD, Matthias Stelljes, Utz Krug, MD, Carsten Muller-Tidow, MD, Thomas Büchner, MD, Wolfgang E Berdel, MD, Maria Francisca Arteaga, PhD

Blood (2016) 128 (22): 2840.

https://doi.org/10.1182/blood.V128.22.2840.2840

Published: 2016

Journal Articles

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

Blood (2016) 128 (5): 686–698.

https://doi.org/10.1182/blood-2016-01-693879

Published: 2016

Includes: Supplemental data

Journal Articles

Allogeneic Stem Cell Transplantation (SCT) for Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) in Elderly Patients (Older than 60 Years)

Michele Pohlen, MD, Christoph Groth, MD, Tim Sauer, MD, Dennis Görlich, Rolf Mesters, MD, Christoph Schliemann, MD, Georg Lenz, MD, Carsten Müller-Tidow, MD, Thomas Büchner, MD, Wolfgang E Berdel, MD, Matthias Stelljes, MD

Blood (2015) 126 (23): 2025.

https://doi.org/10.1182/blood.V126.23.2025.2025

Published: 2015

NARROW

The Differential Impact of Secondary-Type Mutations in a Multinational Cohort of 5311 Intensively Treated Acute Myeloid Leukemia Patients

Secondary-Type Mutations Do Not Impact the Favorable Outcome of NPM1 -Mutated Acute Myeloid Leukemia Patients - Results from a Large Cohort of Intensively Treated Patients

D DX41 -Low Expression Mimics Germline DDX41 -Phenotype in Acute Myeloid Leukemia

Risk Stratification of Patients with RUNX1- mutated Acute Myeloid Leukemia

Secondary Neoplasms in AML Long-Term Survivors: Even More Cancer to Come?

Life Satisfaction and Quality of Life in AML Long-Term Survivors: Primary Results of the AMLCG-Survivorship Study

German AMLCG-Survivorship Study: Anxiety and Depression Symptoms in AML Long-Term Survivors

Sex-Associated Differences in Frequencies and Outcome Prognostication of Recurrent Molecular Features in Adults with Acute Myeloid Leukemia (AML) (AMLCG, CALGB [Alliance])

Validation of the 2022 European Leukemianet Genetic Risk Stratification of Acute Myeloid Leukemia

Quality of Life and Life Satisfaction in AML Long-Term Survivors: Primary Results of the AMLCG-Survivorship Study

Multi-Dimensional Analysis of Adult Acute Myeloid Leukemia (AML) Landscape Cross-Continents Reveals Age Associated Trends in Mutations and Outcomes

High Prevalence of CHF and Diabetes in AML Long-Term Survivors - a Patient Forever?

PTPN11 mutations and Outcomes in Adult Patients with Acute Myeloid Leukemia

DNA Methylation Profiling of AML Reveals Epigenetic Subgroups with Distinct Clinical Outcome

NPM1 Variant Allele Frequency and Outcomes in AML

Aldehyde Dehydrogenase 2 ( ALDH2 ) Expression Predicts a Poor Prognosis in Acute Myeloid Leukemia

PS29MRC - a Novel Predictive Score for Response to Therapy in Acute Myeloid Leukemia

High Expression of ARMCX1 Predicts Poor Survival in Intensively Treated Older Acute Myeloid Leukemia Patients (≥ 60 years)

Spectrum and prognostic relevance of driver gene mutations in acute myeloid leukemia

Allogeneic Stem Cell Transplantation (SCT) for Acute Myeloid Leukemia (AML) and High-Risk Myelodysplastic Syndrome (MDS) in Elderly Patients (Older than 60 Years)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only